Evidence map›Paper›PMID 39772630›Full record

ReviewJournal of bacteriology2025

Functions of nitroreductases in mycobacterial physiology and drug susceptibility.

Ifeanyichukwu E Eke, Robert B Abramovitch

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Antimicrobial agents and chemotherapy · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ifeanyichukwu E EkeDepartment of Microbiology, Genetics & Immunology, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0001-9790-7589
Robert B AbramovitchDepartment of Microbiology, Genetics & Immunology, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0002-4119-4169

Funding

Screening for inhibitors of M. tuberculosis persistence-related lipid metabolismR21AI105867 · NIAID · MICHIGAN STATE UNIVERSITY · PI ABRAMOVITCH, ROBERT B · 2013 to 2014
$392k
Characterizing new M. tuberculosis inhibitors discovered in the Molecular Libraries Small Molecule RepositoryR03AI153454 · NIAID · MICHIGAN STATE UNIVERSITY · PI ABRAMOVITCH, ROBERT B · 2020 to 2021
$149k
AgBioResearch, Michigan State University (MSU AgBioResearch)HHS | National Institutes of Health (NIH) R21 AI105867,R03 AI153454NIAID NIH HHS R03 AI153454NIAID NIH HHS R21 AI105867
6 · The paper itself

Abstract

Tuberculosis is a respiratory infection that is caused by members of the

Indexed as

Antitubercular AgentsMycobacterium tuberculosisNitroreductasesBacterial ProteinsHumansProdrugsAntitubercular AgentsBacterial ProteinsNitroreductasesProdrugsantimicrobialsMycobacteriumnitroreductase

Identifiers

PMID39772630
PMCPMC11841060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.